The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Pros and Cons in the UK
Mounjaro (tirzepatide) is a prescription weight loss injection licensed in the UK for adults with obesity or overweight with health conditions. But like any medication, it has both advantages and limitations worth understanding. This guide breaks down the real pros and cons of Mounjaro in a UK context—including NHS eligibility, how it works, what side effects to expect, and how costs compare. Whether you're considering this medication through the NHS or privately, understanding both sides will help you make an informed decision with your GP or prescriber.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What Are the Main Advantages of Mounjaro?
Mounjaro's key benefits include its dual mechanism—activating both GIP and GLP-1 hormone pathways—which clinical trials suggest may produce greater weight loss than single-mechanism alternatives. The SURMOUNT-1 trial showed participants on the maximum 15mg dose lost an average of approximately 20.9% of their body weight over 72 weeks, alongside a reduced-calorie diet and increased physical activity. It's a once-weekly injection, making it more convenient than daily medications. The KwikPen device is relatively simple to use, and storage is straightforward (refrigerate unopened, room temperature up to 30 days after first use). For eligible UK adults, there's potential NHS access through tier 3 specialist weight management services, which can significantly reduce costs. Individual results vary, but many users report reduced appetite, fewer cravings, and improved control over food intake—factors that support sustainable lifestyle change. You can explore projected outcomes using our GLP-1 weight loss calculator to see potential results at different doses.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
What Are the Main Drawbacks and Considerations?
Mounjaro drawbacks include common side effects—nausea, diarrhoea, constipation, and stomach pain affect many users, especially in the first weeks. Serious side effects are rare but possible (pancreatitis, gallbladder issues). The dose titration schedule is gradual (minimum 4 weeks per dose), so reaching an effective dose takes 4–5 months. NHS access is limited and varies significantly by region—many areas have lengthy waiting lists or restricted tier 3 services. Private costs range from £129–£320 monthly depending on dose. Weight regain is common after stopping (weight typically returns within months to years). Mounjaro is unsuitable in pregnancy, breastfeeding, or for under-18s. Long-term safety data is still emerging. Unlike GLP-1 medications such as Wegovy, Mounjaro's newer mechanism means less long-term real-world evidence. You can assess your personal eligibility and BMI context using our free BMI calculator, then discuss specific pros and cons with your GP based on your individual health profile.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is Mounjaro available on the NHS in the UK?
Mounjaro (tirzepatide) has been approved by NICE for NHS use within specialist tier 3 weight management services. However, availability varies significantly by region and ICB (Integrated Care Board). Access typically requires referral from your GP and assessment by a specialist service. Waiting lists can be very long in some areas. Private prescription via online clinics is an alternative route without NHS referral.
How does Mounjaro compare to Wegovy for weight loss?
Both are once-weekly injections licensed for UK weight loss. Mounjaro uses dual GIP+GLP-1 mechanism; Wegovy uses GLP-1 only. SURMOUNT-1 trial data showed Mounjaro produced approximately 15–clinically studied weight loss; Wegovy's STEP trial showed approximately 15%. Mounjaro may offer greater average loss, but individual results vary significantly. Your prescriber can advise which is more suitable for you.
What are the most common side effects of Mounjaro?
Very common side effects include nausea, diarrhoea, constipation, vomiting, and stomach pain—usually mild to moderate and often improving over time. Injection site reactions (redness, bruising) are common. Serious side effects are rare but include pancreatitis (severe stomach pain), gallbladder problems, and allergic reactions. Always report persistent or severe symptoms to your GP immediately.
How long does it take to reach an effective Mounjaro dose?
Mounjaro uses a gradual dose titration schedule, starting at 2.5mg and increasing every 4 weeks if tolerated. The maximum dose is 15mg weekly. It typically takes 16–20 weeks (4–5 months) to reach the highest dose. Some people benefit at lower doses; others require the maximum dose for best results.
What happens to weight after stopping Mounjaro?
Weight regain is common after discontinuing any weight loss medication. Without continued medication, appetite hormone signals typically return to baseline, and weight often gradually increases over months to years. Long-term weight management typically requires ongoing medication, sustained dietary changes, and increased physical activity.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.